Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune disease marked by inflammation of the joints, sometimes with prominent extra-articular manifestations. The disease is initially characterized by inflammation of the synovial membranes (synovitis) of peripheral joints. If RA is uncontrolled, many cases ultimately lead to destruction of the articular cartilage, bone erosions, and significant deformity, disability, and morbidity in 10-20 years from onset.
The etiology of rheumatoid arthritis is unknown, but likely involves interaction of genetic and environmental factors. The typical presentation consists of a gradual onset of polyarticular symmetric arthritis of small joints and is characterized by pain, morning stiffness, and joint swelling. Among the early articular sites of disease are the metacarpophalangeal and proximal interphalangeal joints of the fingers, the metacarpophalangeal and interphalangeal joints of the thumbs, the wrists, and the metatarsophalangeal joints of the toes. Extra-articular manifestations may include dry eye syndrome (which occurs with variable severity in up to 50% of patients), pericarditis, episcleritis, scleritis, subcutaneous nodules, vasculitis, splenomegaly, fatigue, and mild anemia. The disease is associated with increased risk of lymphoma, infection, and early cardiovascular disease.
RA affects 0.5%-1% of the adult population in the US. Prevalence varies widely among ethnic and regional groups. Other risk factors include:
Age. The typical age of onset is 30-55 years, although the disease may occur at any age.
Gender. RA is 2-3 times more common in women than in men.
Genetics. The disease generally does not aggregate in families. Nonetheless, a multitude of genes may play a role in the development of RA. For example, the HLA-DRB1 gene contains a short disease-conferring sequence.
Cigarette smoking. Current or previous history of cigarette smoking has been shown to increase likelihood of RA in genetically susceptible populations.
The diagnosis of rheumatoid arthritis is largely clinical; no single laboratory or imaging study is pathognomonic. In order to even consider initial testing, a patient should present with swelling in at least one joint that cannot be explained by an alternative diagnosis. It is important to obtain a detailed history and perform a thorough physical examination as other illnesses may initially present with similar findings. The American College of Rheumatology in conjunction with the European League Against Rheumatism updated their diagnostic criteria in 2010 and now use a scoring system in order to diagnose RA. Various signs, symptoms, and laboratory findings are taken into account, and a score of 6 or more out of 10 is diagnostic for RA. The individual criteria need not all be present simultaneously; therefore, the diagnosis can be established over time if additional criteria are met.
Criteria for diagnosis of RA include the following:
- Joint involvement
- Serology: rheumatoid factor and anti-cyclic citrullinated peptide
- Acute phase reactants: ESR and CRP
- Duration of symptoms
In “typical” cases, patients will report symmetric morning stiffness lasting for at least 1 hour, which has been present for more than 6 weeks. Pain and stiffness often affect the proximal interphalangeal, metacarpophalangeal, or wrist joints, and almost never affects the distal interphalangeal joints.
Radiographic imaging should be obtained to establish a baseline to allow later comparison to assess disease progression.
If a joint effusion is present, aspiration with fluid evaluation can be beneficial if there is concern for infectious or crystal-related etiology.
Treatment of RA generally includes physical therapy, dietary intervention (see Nutritional Considerations below), anti-inflammatory medication, and Disease-modifying antirheumatic drugs (DMARDs). Occupational therapy and social work referrals may also be considered based on patient needs. Early referral to a rheumatologist is important both for further evaluation and also for starting treatment. Therapy is designed with a “treat to target” approach aiming to achieve remission. Reducing disease activity to the extent possible will slow disease progression.
Extra-articular manifestations are treated according to the specific syndrome (e.g., lubricating eye drops for dry eye syndrome).
Weight loss should be encouraged for overweight patients to decrease stress on the weight-bearing joints. Adequate rest and smoking cessation are also beneficial. Surgery is reserved for severe, debilitating disease.
Regular low-impact exercise, including aerobic exercises, judicious strength training, and range-of-motion exercises, is important for preserving joint function and preventing contractures and muscle atrophy. Water-based exercise does not appear to increase the rate of large joint damage. A reasonable prescription for exercise in RA patients may emphasize low-intensity water-based (and sometimes land-based) exercises. Heat and hydrotherapy, relaxation techniques, and passive and active joint exercises are also helpful. There is evidence that yoga can reduce pain in RA patients.
DMARDs are a mainstay of RA therapy and may prevent joint damage, preserve joint integrity and function, improve quality of life, and reduce health care costs. These drugs include hydroxychloroquine, sulfasalazine, methotrexate, and leflunomide. Azathioprine and cyclosporine are no longer in US guidelines but are still being used in Europe. Many DMARDs have potentially serious side effects and require close monitoring.
If a DMARD fails to achieve targeted improvement in disease activity (or is contraindicated), then treatment is often augmented by combining DMARDs or initiating a biologic agent. Newer agents that have proven beneficial for rheumatoid arthritis include anti-tumor necrosis factor α (TNF- α) agents (etanercept, infliximab, adalimumab, certolizumab pegol, golimumab), a selective costimulation modulator (abatacept), interleukin-6 receptor antagonists (tocilizumab, sarilumab), a B-cell depleting agent (rituximab), an interleukin-1 receptor antagonist (anakinra), and an oral small molecule janus kinase inhibitor (tofacitinib). Other agents continue to be developed and show promise in treating RA and other autoimmune diseases.
Anti-inflammatory medications are first-line treatments for pain relief. Steroids are generally more effective than NSAIDs. Oral steroids may be used for short-term treatment of RA flares or for long term treatment of moderate or high disease activity, while intra-articular steroids may be considered for individual joint pain no more frequently than every 3 months. Long-term steroid use has gastrointestinal, cardiovascular, integumentary, and musculoskeletal complications. The physician should consider prophylaxis against pneumocystis jirovecii with any anticipated long-term steroid use. When steroids are used, dietary supplementation with adequate vitamin D and calcium should be instituted. Patients who require steroid therapy beyond 3 months may benefit from the addition of a bisphosphonate, such as alendronate.
Rheumatoid arthritis may often be ameliorated with diet changes and some cases of complete remission have been reported. Studies have shown both symptomatic and laboratory evidence of improvement with vegetarian diets and various elimination diets. Omega-3 fatty acids may reduce pain and inflammation in RA. The key nutritional issues in RA are summarized below:
Vegan and Vegetarian Diets
Some evidence indicates that patients who follow vegan or vegetarian diets may experience significant improvement in RA symptoms. Researchers in Norway found that a vegan diet led to reductions in pain, swelling, and morning stiffness, as well as improvements in C-reactive protein. Another study found significant improvements in RA symptoms with a 4-week vegan diet intervention.
Some studies have focused on meat specifically. Although one study found no connection between meat and RA, others have found that higher intakes of meat , and elevated serum cholesterol concentrations , are associated with increased risk of developing this disease. In addition, the removal of meat products from the diet has shown to improve symptoms for the long term. Patients with RA are known to be at higher risk for cardiovascular disease and to have higher serum levels of oxidized low-density lipoprotein (LDL).
Eliminating Diet Triggers
Clinical tests have shown that consumption of allergenic foods increases pro-inflammatory chemicals (cytokines) that are considered a hallmark of RA. Studies have shown that eliminating certain foods brings symptomatic improvement., To identify trigger foods, an elimination diet can easily be instituted on an outpatient basis. The procedure is as follows:
Start with a simple baseline diet, excluding foods that are more common triggers (dairy products, corn, meats, wheat, oats and rye, eggs, citrus fruits, potatoes, tomatoes, nuts, and coffee) and including only those foods not implicated in arthritis, listed below:
Cooked or dried fruits (cherries, cranberries, pears, prunes).
Cooked green, yellow, and orange vegetables (artichokes, asparagus, broccoli, chard, collards, lettuce, spinach, string beans, squash, sweet potatoes, tapioca, and taro).
Plain or carbonated water.
Condiments (modest amounts of salt, maple syrup, vanilla extract).
After approximately 4 weeks on this diet, if symptoms have improved or disappeared, patients may introduce previously eliminated foods one at a time, every 2 days. Patients should keep a food diary and add these foods in generous amounts to observe which ones cause arthritic symptoms. Foods listed above as common triggers should be added last. A newly added food associated with increased joint pain should be removed from the diet for 1-2 weeks, and then reintroduced to see if the same reaction occurs. If no symptoms are experienced, that food can be kept in the diet.
In general, fruits and vegetables seem to be protective against the development of RA. Poor antioxidant status may be a risk factor for RA. Studies have shown that a higher intake of certain carotenoids found in fruits and vegetables may protect against developing RA. , Foods containing beta-cryptoxanthin (e.g., citrus fruits) and zeaxanthin (e.g., green leafy vegetables) may be particularly helpful. The European Prospective Investigation of Cancer (EPIC)–Norfolk study of more than 25,000 individuals found that those consuming the highest amounts of these carotenoids had half the risk for developing inflammatory polyarthritis, compared with those consuming the least amount. Lower serum levels of vitamin E and selenium were also found to predict the development of rheumatoid arthritis.
A diet low in arachidonic acid, an omega-6 fatty acid found in animal products, was found to ameliorate inflammation in patients with RA. This effect was strengthened by omega-3 fatty acid supplementation.Studies have also found a lower incidence of arthritis in Mediterranean countries, which may be attributable to olive oil intake,, possibly because this fat negates the production of pro-inflammatory chemicals that affect RA patients. Supplementing with gamma-linolenic acid (GLA) was found to be an effective strategy for reducing the symptoms of RA, and supplementation with a combination of GLA and omega-3 fatty acids was found to both reduce symptoms and decrease the need for NSAIDs in RA patients. , These fatty acids appear to work by blocking production of arachidonic acid-derived inflammatory mediators, an effect that is achievable with vegan diets as well (see above).
Patients with RA are often treated with methotrexate, a folate antagonist that can increase plasma homocysteine concentrations. Folate supplementation is recommended to prevent methotrexate-induced toxicity, folate deficiency, and hyperhomocysteinemia.
Vegetarian diet, nondairy, to be tried on a prospective basis.
Nutrition consultation: to advise patient in the above diet, consider elimination diet to evaluate for occult food allergies, and arrange follow-up to assist patient in long-term dietary modifications.
Physical and occupational therapy consultations: to recommend an individualized exercise program.
What to Tell the Family
RA can be ameliorated through dietary measures and medication as appropriate for disease severity. Diet changes can be helpful, sometimes dramatically so, and due to the hereditary component of RA, family members may benefit from similar diet changes. The patient should stay physically active through regular low-impact exercise, light strength training, and range-of-motion exercises. Exercises learned in physical therapy should be incorporated into the daily exercise routine.
- Helmick CG et al: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15, 2008 [PMID:18163481]
- Scott DL, Wolfe F, Huizinga TW: Rheumatoid arthritis. Lancet 376:1094, 2010 [PMID:20870100]
- Bang SY et al: Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum 62:369, 2010 [PMID:20112396]
- Aletaha D et al: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580, 2010 [PMID:20699241]
- de Jong Z, Vliet Vlieland TP: Safety of exercise in patients with rheumatoid arthritis. Curr Opin Rheumatol 17:177, 2005 [PMID:15711232]
- Büssing A et al: Effects of yoga interventions on pain and pain-associated disability: a meta-analysis. J Pain 13:1, 2012 [PMID:22178433]
- Singh JA et al: 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 68:1, 2016 [PMID:26545825]
- Yale SH, Limper AH: Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5, 1996 [PMID:8538233]
- Kjeldsen-Kragh J et al: Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 338:899, 1991 [PMID:1681264]
- Benito-Garcia E et al: Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res Ther 9:, 2007 [PMID:17288585]
- Pattison DJ et al: Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 50:3804, 2004 [PMID:15593211]
- Grant WB: The role of meat in the expression of rheumatoid arthritis. Br J Nutr 84:589, 2000 [PMID:11177171]
- Turesson C et al: High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study. Arthritis Res Ther 17:, 2015 [PMID:26458977]
- Heliövaara M et al: Serum cholesterol and risk of rheumatoid arthritis in a cohort of 52 800 men and women. Br J Rheumatol 35:255, 1996 [PMID:8620301]
- Kim SH et al: Serum oxidized low-density lipoproteins in rheumatoid arthritis. Rheumatol Int 24:230, 2004 [PMID:14628150]
- Karatay S et al: The effect of individualized diet challenges consisting of allergenic foods on TNF-alpha and IL-1beta levels in patients with rheumatoid arthritis. Rheumatology (Oxford) 43:1429, 2004 [PMID:15304675]
- van de Laar MA, van der Korst JK: Food intolerance in rheumatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes. Ann Rheum Dis 51:298, 1992 [PMID:1575571]
- Boeing H et al: Critical review: vegetables and fruit in the prevention of chronic diseases. Eur J Nutr 51:637, 2012 [PMID:22684631]
- Heliövaara M et al: Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 53:51, 1994 [PMID:8311556]
- Cerhan JR et al: Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 157:345, 2003 [PMID:12578805]
- Comstock GW et al: Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 56:323, 1997 [PMID:9175934]
- Pattison DJ et al: Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study. Am J Clin Nutr 82:451, 2005 [PMID:16087992]
- Knekt P et al: Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis. Epidemiology 11:402, 2000 [PMID:10874546]
- Adam O et al: Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis. Rheumatol Int 23:27, 2003 [PMID:12548439]
- Linos A et al: Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables? Am J Clin Nutr 70:1077, 1999 [PMID:10584053]
- Little C, Parsons T: Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev [PMID:11279784]
- Lau CS, Morley KD, Belch JJ: Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis--a double-blind placebo controlled study. Br J Rheumatol 32:982, 1993 [PMID:8220938]
- Belch JJ et al: Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis 47:96, 1988 [PMID:2833184]
- Whittle SL, Hughes RA: Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology (Oxford) 43:267, 2004 [PMID:14963199]
- Morgan SL et al: Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25:441, 1998 [PMID:9517760]
- Goldberg RJ, Katz J: A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain. Pain 129:210, 2007 [PMID:17335973]